BeyondAirInc . (NASDAQ:XAIR) Raised to Buy at ValuEngine

ValuEngine upgraded shares of BeyondAirInc . (NASDAQ:XAIR) from a hold rating to a buy rating in a report issued on Tuesday morning, ValuEngine reports.

BeyondAirInc . stock traded up $0.04 during mid-day trading on Tuesday, reaching $4.50. The company had a trading volume of 161 shares, compared to its average volume of 21,248. BeyondAirInc . has a 52 week low of $3.11 and a 52 week high of $6.25. The stock’s 50 day simple moving average is $4.71. The stock has a market cap of $46.84 million, a price-to-earnings ratio of -5.36 and a beta of -0.27.

BeyondAirInc . (NASDAQ:XAIR) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.20). The firm had revenue of $0.63 million for the quarter, compared to the consensus estimate of $1.25 million. On average, equities analysts forecast that BeyondAirInc . will post -1.14 EPS for the current fiscal year.

BeyondAirInc . Company Profile

Beyond Air, Inc, a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria.

Recommended Story: What is Green Investing?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for BeyondAirInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondAirInc . and related companies with MarketBeat.com's FREE daily email newsletter.